Millions of Britons, particularly the most vulnerable in their society, probably breathed a sigh of relief on Tuesday when National Health Service leaders introduced the first patient to receive a dose of the experimental Pfizer-BioNTech injection.
People With Severe Allergies Should Not Receive Pfizer’s COVID-19 Vaccine
Headlines with a Voice 